Virtus Biotech ETF-UsdBBPETF
13F holders, Q3 2024 (September 30)14holders +1
2new positions
2sold out
$62.84avg. 13F price*
At the end of Q3 2024, 14 institutions reported holding Virtus Biotech ETF-Usd Inc. (BBP) in their 13F filings, up 1 from Q2 2024. 2 opened new positions and 2 sold out. The largest holders were CWA Asset Management Group, LLC ($1.6M), Royal Bank of Canada ($898K) and Morgan Stanley ($550K).
- Company
- Virtus Biotech ETF-Usd Inc.
- Filed as
- ETFIS SER TR I (Q3 2024)
- CUSIP
- 26923G202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $253K |
| Exits | 2 | $358K |
All 13F filers, Q2 2024 → Q3 2024: 5,263 shares bought and 13,997 shares sold, net −8,734 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| CWA Asset Management Group, LLC | 0.08% | — | 25,289 | $1.6M |
| Royal Bank of Canada | 0.00% | Reduce -0.1% | 14,291 | $898K |
| Morgan Stanley | 0.00% | Add +9.4% | 8,754 | $550K |
| Raymond James Financial Services Advisors, Inc. | 0.00% | Reduce -32.9% | 7,777 | $489K |
| Susquehanna International Group, LLP | 0.00% | Reduce -17.6% | 6,904 | $434K |
| Independent Financial Group, LLC | 0.01% | Add +1.1% | 5,583 | $351K |
| LPL Financial LLC | 0.00% | Add +6.8% | 5,158 | $324K |
| Jag Capital Management, LLC | 0.03% | New | 4,028 | $253K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -43.8% | 3,342 | $210K |
| Cwm, LLC | 0.00% | No change | 717 | $45K |
| JPMorgan Chase & Co. | 0.00% | Add +900.0% | 100 | $6K |
| Glen Eagle Advisors, LLC | 0.00% | No change | 50 | $3K |
| Peoples Bank | 0.00% | No change | 49 | $3K |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 5 | $314 |
"% of holder's portfolio" is BBP's weight in each manager's 13F, not the share of Virtus Biotech ETF-Usd Inc. the manager owns.